Case: We present an unusual case of metachronous multicentric giant cell tumor (GCT) of forearm bones in a 38-year-old male patient with an 8-year follow-up. The diagnosis was established by imaging and histopathology. He underwent multiple surgeries with extraperiosteal resection of lesions with free fibular grafts. No new lesion was detected in the last 3 years. When last seen, the patient was asymptomatic (apart from restricted supination). A literature review is also presented.
Conclusion: Metachronous multicentric GCT involving only the forearm bones is rare. A high index of suspicion is necessary to differentiate it from other polyostotic lesions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2106/JBJS.CC.24.00566 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[A Case of Laparoscopic Liver and Colon Resection for Recurrent Hepatocellular Carcinoma and Metachronous Colon Metastasis of Hepatocellular Carcinoma].
Gan To Kagaku Ryoho
February 2025
Dept. of Gastroenterological Surgery, Akita City Hospital.
An 81-year-old man underwent a partial laparoscopic hepatectomy for tumors in the S7 segment of the liver and was diagnosed with moderately to poorly differentiated hepatocellular carcinoma(HCC). Two years and 10 months later, MRI identified a 10 mm tumor in the S8 segment of the liver, indicative of highly differentiated HCC. Colorectal endoscopy subsequently revealed a submucosal tumor in the transverse colon, with biopsy findings showing features similar to the previous HCC.
View Article and Find Full Text PDFUnusual Presentation of Metachronous Multicentric Giant Cell Tumor of Forearm Bones with Literature Review.
JBJS Case Connect
January 2025
Department of Orthopaedic Surgery, Maulana Azad Medical College & Associated Lok Nayak Hospital, New Delhi, India.
Case: We present an unusual case of metachronous multicentric giant cell tumor (GCT) of forearm bones in a 38-year-old male patient with an 8-year follow-up. The diagnosis was established by imaging and histopathology. He underwent multiple surgeries with extraperiosteal resection of lesions with free fibular grafts.
View Article and Find Full Text PDFReal-world Evidence for Enfortumab Vedotin in Patients with Metastatic Urothelial Cancer: An Austrian Multicentre Study.
Clin Genitourin Cancer
February 2025
Department of Urology, Comprehensive Cancer Centre Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
Article Synopsis
- Enfortumab vedotin (EV) is a new treatment option for patients with advanced urothelial carcinoma who haven't responded to other therapies.
- A study involving 128 patients in Austria showed an objective response rate of 31%, with median progression-free survival of 4.8 months and overall survival of 10.75 months.
- The treatment was found to be feasible and effective, with an acceptable safety profile, although lower efficacy was noted compared to earlier trials, likely due to the patient population being in later therapy lines.
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.
Sci Rep
November 2024
Azienda Ospedale Università di Padova, via Giustiniani 2, Padua, 35128, Italy.
Lynch syndrome is rarely associated with rectal cancer (RC) and thus, metachronous RC has been scarcely investigated. This study aimed to analyze the mucosal immune microenvironment in sporadic and metachronous RC. We analyzed the mucosal immune microenvironment in the 25 metachronous RCs present in the IMMUNOREACT 1 and 2 multicentre observational studies (624 patients).
View Article and Find Full Text PDFPatterns of recurrence in idiopathic orbital myositis.
Graefes Arch Clin Exp Ophthalmol
November 2024
Department of Ophthalmology, The Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Purpose: To characterise patterns of disease recurrence in idiopathic orbital myositis (IOM).
Methods: Multi-centre retrospective longitudinal study of IOM patients. Serial imaging was also analysed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!